Marex Financial (Equity Derivative Business) is Other Financial Services in United Kingdom that focus on derivative products business. They cover business area such as Provider, equity derivative product, fix income security, foreign exchange, credit derivative, future, structured product, individual, corporation, complete assistance, investment.
-
Derivative Products
-
155 Bishopsgate
Level Five
London EC2M 3TQ
England, United Kingdom
Private
Providerequity derivative productfix income securityforeign exchangecredit derivativefuturestructured productindividualcorporationcomplete assistanceinvestment
* We use standard office opening hours in near Marex Financial (Equity Derivative Business)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Marex Financial (Equity Derivative Business) is Other Financial Services business from United Kingdom that founded in - ( years old in ), Marex Financial (Equity Derivative Business) business is focusing on Derivative Products.
Marex Financial (Equity Derivative Business) headquarter office and corporate office address is located in 155 Bishopsgate Level Five London EC2M 3TQ England, United Kingdom.
Marex Financial (Equity Derivative Business) was founded in United Kingdom.
In , Marex Financial (Equity Derivative Business) is currently focus on derivative products sector.
Above is snippet of Google Trends for "derivative products" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Marex Financial (Equity Derivative Business), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
